Evidence-based Medicine Center;
Taizhou Hospital of Zhejiang Province;
Wenzhou Medical University;
Linhai 317000;
Zhejiang Province;
China;
Public Laboratory;
Taizhou Hospital of Zhejiang Province;
Wenzhou Medical University;
Linhai 317000;
Zhejiang Province;
China;
Institute for Hospital Management;
Tsing Hua University;
Shenzhen Campus;
Shenzhen 518055;
Guangdong Province;
China;
Department of Orthopedics;
Taizhou Hospital of Zhejiang Province;
Wenzhou Medical University;
Linhai 317000;
Zhejiang Province;
China;
Psoriasis; Hypoglycemic agents; Thiazolidinediones; Glucagon-like peptide-1 receptor agonists; Dipeptidyl peptidase-4 inhibitors; Biguanides; Antipsoriatic effect; Evidence-based medicine;